Dobutamine magnetic resonance imaging predicts contractile reserve of chronically dysfunctional myocardium: comparison with was fluorine-18 fluorodeoxyglucose positron emission tomography

Chin Med Sci J. 2000 Mar;15(1):29-34.

Abstract

Objective: This study sought to investigate whether low-dose dobutamine-MRI can detect residual myocardial viability in patients with chronic myocardial infarction and, left ventricular dysfunction.

Methods: Eleven patients with chronic myocardial infarction and left ventricular dysfunction were employed for identification of viable myocardium by cine-MRI during dobutamine infusion. All patients underwent coronary angiography and left ventriculography, 18FDG-PET, MRI at rest and stress. The systolic wall thickening measured at rest and during stress was compared with the results of 18FDG-PET, respectively.

Results: A significant difference of either dobutamine-induced systolic wall thickening (SWthstress) or dobutamine-induced contractile reserve (deltaSWth = SWthstress - SWthrest) was present between viable and scar regions (1.0 +/- 0.3 versus -0.3 +/- 0.1, P < 0.01; 1.0 +/- 0.3 versus -0.2 +/- 0.2, P < 0.01).

Conclusions: obutamine-induced contractile reserve can be predicted in the regions of akinesia or dyskinesia at rest when systolic wall thickening was > or = 1.0 mm during dobutamine stimulation.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Cardiotonic Agents / pharmacology
  • Dobutamine* / pharmacology
  • Female
  • Fluorodeoxyglucose F18
  • Heart / diagnostic imaging*
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Myocardial Contraction / drug effects*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / physiopathology*
  • Radiopharmaceuticals
  • Tomography, Emission-Computed
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / physiopathology*

Substances

  • Cardiotonic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dobutamine